New vaccines aim to block malaria transmission in africa

NCT ID NCT06549257

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two experimental vaccines designed to stop the malaria parasite from spreading from person to person. The vaccines target the parasite's development inside mosquitoes, so vaccinated people who get bitten are less likely to pass the infection on. The trial involves 56 healthy volunteers aged 5 to 45 in Burkina Faso, and will check for safety and immune responses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLASMODIUM FALCIPARUM MALARIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut des Sciences et Techniques (INSTech)

    Bobo-Dioulasso, 01 BP 2779, Burkina Faso

More trials for these conditions

Other studies related to the condition(s) this trial covers.